share_log

Eledon Pharmaceuticals | 8-K: Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

SEC announcement ·  Mar 29 04:05
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.